← All stocks

ImmunityBio, Inc.

IBRX Net buying
CIK 0001326110 #1027 in the set updated 18 Sep 2026
Bought (120 mo)
$45.27M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$28.95M
$4.14M on a plan · $15.22M straight out of an exercise
Sold at will
$9.59M
67 of 97 sales
Net
+$16.32M
+$35.68M against sales at will

By person

17 insiders · 115 transactions
6.4×

Richard Adcock holds 6.4 times base salary in stock. $5.34M of shares against $831.67K in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Adcock last reported holding, valued at $9.50, the price Common Stock was last bought or sold at on the open market here, on 2 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SOON-SHIONG PATRICK
See remarks
$44.97M (1)
+$44.97M
280,776,784
26.49%
$2.67B
Simon Barry J.
Director
$17.28M (27) scheduled
−$17.28M
2,802,788
0.2645%
$26.64M
−14.1%
GORLIN STEVE
Director
$3.11M (34)
−$3.11M
230,941
0.0218%
$2.19M
−78.8%
Selecky Christobel
Director
$3.00M (6) scheduled
−$3.00M
0
0.0000%
$0.00
Cohen Cheryl
Director
$2.26M (6) scheduled
−$2.26M
125,386
0.0118%
$1.19M
Thomas John C
Director
$1.86M (19)
−$1.86M
207,477
0.0196%
$1.97M
−37.8%
Nelson Sonja
Chief Financial Officer
$780.40K (2) scheduled
−$780.40K
15,410
0.0015%
$146.45K
DRISCOLL FREDERICK W
Director
$668.05K (3)
−$668.05K
109,235
0.0103%
$1.04M
BLASZYK MICHAEL D
Director
$198.02K (3)
+$198.02K
265,582
0.0251%
$2.52M
+431.2%
Brennan John Owen
Director
$70.70K (3)
+$70.70K
25,000
0.0024%
$237.58K
Clark Wesley
Director
$20.37K (1)
+$20.37K
8,000
0.0008%
$76.03K
+700.0%
Adcock Richard
CEO & President
$17.00K (2)
+$17.00K
562,274
0.0531%
$5.34M
Kusserow Richard
Director
394,053
0.0372%
$3.74M
+6.4%
Sachs David C.
Chief Financial Officer
300,143
0.0283%
$2.85M
+1,491%
POTTS JOHN T JR
Director
159,253
0.0150%
$1.51M
+17.5%
LAUER REGAN J
Chief Accounting Officer
115,875
0.0109%
$1.10M
Tajak Richard J.
Chief Financial Officer
12,876
0.0012%
$122.37K
+291.0%
Insider
Date
Role
Action
Shares
Price
Amount
Cohen Cheryl
2 Jul 2026
Director
Sold after exercise
131,210
$9.50
$1.25M
Selecky Christobel
1 Jul 2026
Director
Sold after exercise
159,478
$9.02
$1.44M
Selecky Christobel
30 Jun 2026
Director
Sold after exercise
1,000
$9.00
$9.00K
Selecky Christobel
29 Jun 2026
Director
Sold after exercise
95,722
$9.01
$862.22K
Selecky Christobel
23 Feb 2026
Director
Sold after exercise
25,000
$10.00
$250.00K
Selecky Christobel
20 Jan 2026
Director
Sold after exercise
25,000
$7.51
$187.65K
Selecky Christobel
16 Jan 2026
Director
Sold after exercise
50,000
$5.00
$250.00K
Simon Barry J.
5 Feb 2021
See remarks
Sold after exercise
22,100
$23.09
$510.27K
Simon Barry J.
2 Feb 2021
See remarks
Sold after exercise
82,070
$20.65
$1.69M
Simon Barry J.
28 Jan 2021
See remarks
Sold after exercise
11,304
$20.53
$232.12K
Simon Barry J.
27 Jan 2021
See remarks
Sold after exercise
36,626
$20.61
$754.95K
Nelson Sonja
12 Jan 2021
Chief Financial Officer
Sold after exercise
16,364
$15.00
$245.46K
Nelson Sonja
4 Jan 2021
Chief Financial Officer
Sold after exercise
39,271
$13.62
$534.94K
Simon Barry J.
22 Dec 2020
See remarks
Sold after exercise
130,000
$18.05
$2.35M
Simon Barry J.
21 Jul 2020
See remarks
Sold after exercise
1,565
$15.50
$24.26K
Simon Barry J.
20 Jul 2020
See remarks
Sold after exercise
128,435
$15.53
$2.00M
Simon Barry J.
8 Jul 2020
See remarks
Sold after exercise
39,950
$13.14
$524.76K
Simon Barry J.
30 Jun 2020
See remarks
Sold after exercise
9
$13.00
$117.00
Simon Barry J.
23 Jun 2020
See remarks
Sold after exercise
29,609
$13.01
$385.13K
Simon Barry J.
22 Jun 2020
See remarks
Sold after exercise
10,432
$13.01
$135.71K
Simon Barry J.
22 Jun 2020
See remarks
Sold after exercise
80,000
$10.55
$843.66K
Simon Barry J.
22 Jun 2020
See remarks
Sold after exercise
66,263
$9.43
$624.81K
Simon Barry J.
19 Jun 2020
See remarks
Sold after exercise
13,737
$9.00
$123.64K

What was left out

Form 4 filings counted 196
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 23
Sales at will 67
Transactions with no price 0
Shares from compensation/vesting 609,711,941
Sales filed before the plan box existed 67
History held since 9 Sep 2016